Variability in Outcomes for Patients with Intermediate-risk Prostate Cancer (Gleason Score 7, International Society of Urological Pathology Gleason Group 2–3) and Implications for Risk Stratification: A Systematic Review-Reference-Cited by-同舟云学术

Variability in Outcomes for Patients with Intermediate-risk Prostate Cancer (Gleason Score 7, International Society of Urological Pathology Gleason Group 2–3) and Implications for Risk Stratification: A Systematic Review

Published:2017-10 Issue:4-5 Volume:3 Page:487-497
ISSN:2405-4569
Container-title:European Urology Focus
language:en
Short-container-title:European Urology Focus

Author:

Kane Christopher J.,Eggener Scott E.,Shindel Alan W.,Andriole Gerald L.

Publisher

Elsevier BV

Subject

Urology

Reference50 articles.

1. Who's too old to screen? Prostate cancer in elderly men;Mistry;Can Urol Assoc J,2009

2. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2012. Bethesda, MD: National Cancer Institute; 2015. http://seer.cancer.gov/csr/1975_2012.

3. Active surveillance for the management of localized prostate cancer: guideline recommendations;Morash;Can Urol Assoc J,2015

4. Trends in management for patients with localized prostate cancer, 1990-2013;Cooperberg;JAMA,2015

5. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients;Stamey;J Urol,1989

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Novel Artificial Intelligence–powered Tool for Precise Risk Stratification of Prostate Cancer Progression in Patients with Clinical Intermediate Risk;European Urology;2024-09

2. The 2012 Briganti nomogram not only predicts lymph node involvement but also disease progression in surgically treated intermediate-risk prostate cancer patients with PSA <10 ng/mL, ISUP grade group 3, and clinical stage up to cT2b;International braz j urol;2024-08

3. Direct three-dimensional segmentation of prostate glands with nnU-Net;Journal of Biomedical Optics;2024-03-01

4. Development and Validation of an Explainable Radiomics Model to Predict High-Aggressive Prostate Cancer: A Multicenter Radiomics Study Based on Biparametric MRI;Cancers;2024-01-01

5. The grade of individual prostate cancer lesions predicted by magnetic resonance imaging and positron emission tomography;Communications Medicine;2023-11-09